Target intelligence / Profile preview

Chromosome 1 open reading frame 159 (C1orf159)

Target
C1orf159
Molecular classification
Other (single-pass membrane protein, DUF4501 domain, not assigned to a characterized receptor, enzyme, transporter, ion channel, transcription factor, or histone modification)
01

Overview

Chromosome 1 open reading frame 159 (C1orf159) encodes a largely uncharacterized, evolutionarily conserved, proline- and arginine-rich protein whose main feature is a DUF4501 domain of unknown function. The protein is predicted to be a single-pass, membrane-associated protein with a signal peptide and a transmembrane domain. Its main isoform is 380 amino acids (40.38 kDa) but alternative splicing produces additional isoforms. C1orf159 is thought to act as a scaffold/adaptor protein, possibly involving protein-protein interactions and membrane localization, and may play a role in brain development and protein ubiquitination. While its molecular function remains unclear, it has prognostic significance in several cancers. High expression correlates with poor prognosis in renal and liver cancer and better prognosis in urothelial cancer. There are no known drugs targeting C1orf159 and no established mechanism of action for therapeutics. The gene is located at chromosome 1p36.33.

Other names
Uncharacterized protein C1orf159UNQ2998/PRO9739FLJ20584C1orf159
02

Biological functions

Possibly scaffold/adaptor proteinprotein-bindingprotein ubiquitinationpossibly involved in brain development
03

Disease associations

Cancer (prognostic marker: negative in renal and liver cancer, positive in urothelial cancer)Congenital myasthenic syndrome
04

Biomarkers

C1orf159 is an unfavorable prognosis marker for renal and liver cancer, and a favorable prognosis marker for urothelial cancer

Beyond the preview

Go deeper on Chromosome 1 open reading frame 159 (C1orf159).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromosome 1 open reading frame 159 (C1orf159).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call